Stegall leaves Dudnyk and takes new role at Group DCA

Allen Stegall has left his role as president of Dudnyk Healthcare Group, Horsham, Pa., and joined Group DCA, an online healthcare communications company, as vice president of electronic publishing and market research.
Stegall, a veteran healthcare marketer, brings 22 years of experience to Group DCA. He began his career at Pfizer as a sales representative and later worked at both Rhone Poulenc Rorer and ICI Pharma in various marketing roles before moving over to the agency side of the industry.
Stegall spent eight years on the West coast where he led BioGenesis Communications. Under Stegall's watch, BioGenesis launched several of the most successful biotech products, including Rituxan and Viracept.
Group DCA, formerly Dot Com Advisors, is a privately owned company that was established in 1999.
You must be a registered member of MMM to post a comment.
close

Next Article in Careers

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.